Related Experiment Video
Updated: Jul 9, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Urinary angiotensinogen as a novel mortality predictor in diabetic kidney disease: a propensity-matched analysis from
Sang Heon Suh1,2, Dohyeon Lee3, Hong Sang Choi1,2
1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
Insights
Urinary angiotensinogen (UAGT/Cr) predicts mortality in diabetic kidney disease (DKD) patients but not in those without diabetes. This finding highlights UAGT/Cr as a potential biomarker for stratifying mortality risk in DKD.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Research
Background:
- Diabetic kidney disease (DKD) significantly increases mortality risk.
- Current biomarkers lack precision for stratifying mortality risk in DKD.
- Intrarenal renin-angiotensin-aldosterone system (RAAS) activity is implicated in DKD progression.
Purpose of the Study:
- To investigate urinary angiotensinogen (UAGT) as a predictor of all-cause mortality in chronic kidney disease (CKD) patients with and without diabetes.
- To determine if UAGT reflects intrarenal RAAS activity and its association with mortality risk.
- To assess the utility of UAGT/Cr for risk stratification in DKD.
Main Methods:
- Prospective cohort study of 824 propensity score-matched CKD patients (412 with diabetes, 412 without).
- Baseline urinary angiotensinogen-to-creatinine ratio (UAGT/Cr) categorized into quintiles.
- Cox proportional hazards models used to estimate adjusted hazard ratios (HRs) for all-cause mortality.
Main Results:
- UAGT/Cr independently predicted all-cause mortality in diabetic CKD patients (highest quintile HR 3.61, P < .001).
- A monotonic relationship was observed between UAGT/Cr and mortality in diabetic patients.
- No significant association between UAGT/Cr and mortality was found in non-diabetic CKD patients (P for interaction < .001).
Conclusions:
- Urinary angiotensinogen-to-creatinine ratio (UAGT/Cr) is an independent predictor of all-cause mortality specifically in CKD patients with diabetes.
- UAGT/Cr shows potential as an etiology-specific prognostic biomarker for risk stratification in diabetic kidney disease.
- Findings suggest intrarenal RAAS activity, reflected by UAGT/Cr, plays a critical role in DKD mortality.
Background:
Patients with diabetic kidney disease (DKD) face a substantially higher risk of premature death compared to nondiabetic counterparts, yet accurate biomarkers for stratifying this mortality risk beyond conventional kidney function measures are currently lacking. We investigated whether urinary angiotensinogen (UAGT), reflecting intrarenal renin-angiotensin-aldosterone system activity, predicts all-cause mortality differently among patients with versus without diabetes in chronic kidney disease (CKD).
Methods:
This prospective cohort study included 824 propensity score-matched patients (412 with diabetes and 412 without diabetes) from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease. Participants were categorized into quintiles by baseline urinary angiotensinogen-to-creatinine ratio (UAGT/Cr). Cox proportional hazards models estimated adjusted hazard ratios (HRs) for all-cause mortality.
Results:
During median follow-up of 8.9 years, 149 deaths occurred. In patients with diabetes, the highest UAGT/Cr quintile was independently associated with increased mortality compared to the reference quintile (adjusted HR 3.61, 95% confidence interval 1.67-7.81, P < .001) after adjustment for kidney function, proteinuria, and comorbidities. Penalized spline analysis demonstrated a monotonic relationship between UAGT/Cr and mortality in patients with diabetes. In contrast, no significant association was observed in patients without diabetes (P for interaction <.001). Findings remained robust in sensitivity analyses.
Conclusion:
UAGT/Cr independently predicts all-cause mortality specifically in CKD patients with diabetes but not in those without diabetes, suggesting its potential utility as an etiology-specific prognostic biomarker for risk stratification in DKD.
Related Concept Videos
Diabetic Nephropathy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care